Form 4: Jaguar Health Director James Bochnowski Receives Stock Option Grant

James Bochnowski, a director at Jaguar Health, was granted stock options to purchase 23,200 shares of common stock on October 8, 2024.

Summary

• James Bochnowski, a director of Jaguar Health, Inc., received a stock option grant on October 8, 2024.
• The options allow him to purchase 23,200 shares of Jaguar Health's common stock at an exercise price of $1.29 per share.
• The options were granted under the company's 2014 Stock Incentive Plan and approved by the board of directors.
• The options will vest 100% on October 8, 2025, provided Bochnowski continues to serve on the board.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. It indicates continued alignment of a director with the company's interests.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service on the board.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing performance.

Key Dates

Keywords

stock options, director, Jaguar Health, JAGX, beneficial ownership, Form 4